LETTER
Copper-Catalyzed N-Arylation of Sulfonimidamides
851
(2) (a) Cathers, B.; Schloss, J. Bioorg. Med. Chem. Lett. 1999,
9, 1527. (b) Pennington, R.; Sha, X.; King, S. B. Bioorg.
Med. Chem. Lett. 2005, 15, 2331. (c) Toth, J.; Grindey, G.;
Ehlhardt, W.; Ray, J.; Boder, G.; Bewley, J.; Klingerman,
K.; Gates, S.; Rinzel, S.; Schultz, R.; Weir, L.; Worzalla, J.
J. Med. Chem. 1997, 40, 1018.
Table 5 Sulfonimidamides Bearing a Carbonyl-Free Side Chain
R
CuSO4 (15 mol%)
K2CO3 (2.5 equiv)
PhI (2.5 equiv), DMSO
O
S
O
N
S
N
NH2
H
MW, 10 min, 170 °C
HO
(3) Steurer, M.; Bolm, C. J. Org. Chem. 2010, 75, 3301.
(4) Levchenko, E. S.; Derkach, N. Y.; Kirsanov, A. V. Zh.
Obshch. Khim. 1962, 32, 1208.
O
(30 mol %)
5–7
8
N
H
OH
(5) (a) Jones, M. R.; Cram, D. J. J. Am. Chem. Soc. 1974, 96,
2183. (b) Johnson, C. R.; Jonsson, E. U.; Bacon, C. C.
J. Org. Chem. 1979, 44, 2055. (c) Levchenko, E. S.;
Markovskii, L. N.; Shermolovich, Y. Zh. Org. Khim. 2000,
36, 167.
Entry
Compound
R
Yield (%)
1
2
5
6
Bu
65
99
cyclohexyl
(6) Bentley, R. Chem. Soc. Rev. 2005, 34, 609.
(7) (a) Leca, D.; Toussaint, A.; Mareau, C.; Fensterbank, L.;
Lacôte, E.; Malacria, M. Org. Lett. 2004, 6, 3573.
(b) Di Chenna, P.; Robert-Peillard, F.; Dauban, P.; Dodd,
R. H. Org. Lett. 2004, 6, 4503. (c) Fruit, C.; Robert-
Peillard, F.; Bernardinelli, G.; Müller, P.; Dauban, P.; Dodd,
R. H. Tetrahedron: Asymmetry 2005, 16, 3484.
(8) Collet, F.; Dodd, R. H.; Dauban, P. Org. Lett. 2008, 10,
5473.
O
3
7
75
reactivity on nonelectron-deficient sulfonimidamides was
also unveiled.
(9) (a) Liang, C.; Collet, F.; Robert-Peillard, F.; Müller, P.;
Dodd, R. H.; Dauban, P. J. Am. Chem. Soc. 2008, 130, 343.
(b) Liang, C.; Robert-Peillard, F.; Fruit, C.; Müller, P.;
Dodd, R. H.; Dauban, P. Angew. Chem. Int.Ed. 2006, 45,
4641; Angew. Chem. 2006, 118, 4757.
(10) Azzaro, S.; Fensterbank, L.; Lacôte, E.; Malacria, M. Synlett
2008, 2253.
(11) Ullmann, F. Ber. Dtsch. Chem. Ges. 1903, 36, 2382.
(12) (a) Evano, G.; Blanchard, N.; Toumi, M. Chem. Rev. 2008,
108, 3054. (b) Ley, S. V.; Thomas, A. W. Angew. Chem.
Int.Ed. 2003, 42, 5400; Angew. Chem 2003, 115, 5558. (c)
For the first catalytic asymmetric Ullmann-type C–C bond
coupling reaction using CuI as catalyst and an enantiopure 4-
hydroxyproline ligand, see : Xie, X.; Chen, Y.; Ma, D. J. Am.
Chem. Soc. 2006, 128, 16050.
(13) Worch, C.; Bolm, C. Synthesis 2008, 739.
(14) For the synthesis of enantioenriched sulfonimidamides, see:
(a) ref. 7c and 9a. (b) Worch, C.; Atodiresei, I.; Raabe, G.;
Bolm, C. Chem. Eur. J. 2010, 16, 677. (c) Toth, J. E.; Ray,
J.; Deeter, J. J. Org. Chem. 1993, 58, 3469.
Supporting Information for this article is available online at
Acknowledgment
This work was supported by the UPMC, CNRS, and IUF (MM, LF).
FR2769 is gratefully acknowledged for technical assistance.
References and Notes
(1) For recent reviews on stereogenic sulfur compounds, see:
(a) Robak, M. T.; Herbage, M. A.; Ellman, J. A. Chem. Rev.
2010, 110, 3600. (b) Zhou, P.; Chen, B. C.; Davis, F. A.
Tetrahedron 2004, 60, 8003. (c) Paitoon, R.; Harmata, M.
Chemtracts 2006, 19, 143. (d) Collet, F.; Dodd, R. H.;
Dauban, P. Chem. Rev. 2009, 34, 5061. (e) Carreño, M. C.;
Hernandez-Torres, G.; Ribagorda, M.; Urbano, A. Chem.
Commun. 2009, 41, 6129.
(15) Reduction of nitrogen containing sulfur(VI) compounds is
not unprecedented. For a similar reaction, see: Harmata, M.;
Zheng, P. Org. Lett. 2007, 9, 5251.
Synlett 2011, No. 6, 849–851 © Thieme Stuttgart · New York